Timely and relevant thoracic oncology news brought to you by the only global association dedicated to the multidisciplinary study of lung cancer.

Timely and relevant thoracic oncology news brought to you by the only global association dedicated to the multidisciplinary study of lung cancer.

Gideon M. Blumenthal, MD

|

By

|

Estimated Read Time:

1 minute
Names & News

Gideon M. Blumenthal, MD was named Acting Deputy Director, Office of Hematology & Oncology Products, US Food and Drug Administration, Silver Spring, US. Prior to this appointment, Dr. Blumenthal was Clinical Team Leader for Thoracic Oncology and Head and Neck Cancer and Scientific Liaison for Lung Cancer in the Division of Oncology Products, Office of New Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, US.

About the Authors

Share this Article:

Recent Posts

View ILCN Archives

Provider Resources